Geoffrey M. Parker, Director at ChemoCentryx, Inc. (CCXI), sold 59,140 shares at $35.32 ($2.2M) on 2020-03-23, disclosed to the SEC on 2020-03-25.
Open-market sale of $2.2M CCXI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.43 | 3,199 | $110K | 5.1% |
| 2 | $34.43 | 3,199 | $110K | 5.1% |
| 3 | $35.32 | 2,801 | $99K | 4.6% |
| 4 | $35.32 | 2,801 | $99K | 4.6% |
| 5 | $36.72 | 9,181 | $337K | 15.5% |
| 6 | $36.72 | 9,181 |
| $337K |
| 15.5% |
| 7 | $37.40 | 13,959 | $522K | 24.1% |
| 8 | $37.40 | 13,959 | $522K | 24.1% |
| 9 | $38.21 | 860 | $33K | 1.5% |
| Total | $36.68 avg | 59,140 | $2.2M | 100% |
| Filing → |
| ALLO | SELL | 2025-10-23 | $46K | — | Filing → |
| PRGO | BUY | 2025-08-20 | $201K | — | Filing → |
| PRGO | BUY | 2025-05-14 | $95K | — | Filing → |